Another point to consider with regards to MESOBLAST's bone marrow mesenchymal stem cells is the fact that bone marrow tends to be very high in white blood cells and low in the mesenchymal cells. Isolating stem cells from fat tissue is now the preferred route not only because it’s easier on the patient, but fat also contains a higher population of mesenchymal cells and fewer white blood cells.
- Forums
- ASX - By Stock
- riken temcell
Another point to consider with regards to MESOBLAST's bone...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.01M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 52223 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 6089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 52223 | 0.205 |
3 | 110000 | 0.200 |
2 | 68825 | 0.195 |
3 | 122713 | 0.190 |
3 | 65055 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 6089 | 2 |
0.245 | 8100 | 1 |
0.250 | 9225 | 2 |
0.255 | 187726 | 1 |
0.270 | 30000 | 1 |
Last trade - 10.53am 15/08/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online